Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COP9 signalosome complex subunit 8 (COPS8) is the smallest of eight protein subunits forming the highly conserved COP9 signalosome (CSN) complex, which is a key regulator in multiple cellular signaling pathways. The CSN complex is structurally and functionally related to the 19S regulatory particle of the 26S proteasome and plays a critical role in regulating ubiquitin ligase activity, particularly by deneddylating cullin proteins within SCF-type E3 ubiquitin ligase complexes. This regulation is essential for controlling protein turnover and modulating signaling cascades. Mutations or dysfunction in COPS8 have been linked to several genetic disorders and may also play roles in cancer pathogenesis through effects on proteostasis and cell cycle regulation[1][2][4][8].
Not applicable (no known direct-acting drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COP9 signalosome complex subunit 8 (COPS8).